-+ 0.00%
-+ 0.00%
-+ 0.00%

Altimmune names Richard Menziuso principal accounting officer, global controller VP

PUBT·09/29/2026 11:05:15
Listen to the news
Altimmune names Richard Menziuso principal accounting officer, global controller VP
  • Altimmune appointed Richard Menziuso as vice president, global controller, principal accounting officer, effective Sept. 29, 2026.
  • Menziuso previously served as vice president, corporate controller at Centessa Pharmaceuticals from 2021 until its 2026 acquisition by Eli Lilly.
  • Earlier roles included finance leadership posts at Thermo Fisher Scientific, Axovant Gene Therapies, PricewaterhouseCoopers, Bristol-Myers Squibb.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001326190-26-000056), on September 29, 2026, and is solely responsible for the information contained therein.